"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
STATICIN (erythromycin topical solution 1.5%) is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Last reviewed on RxList: 2/3/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Staticin Information
Report Problems to the Food and Drug Administration
Find out what women really need.